| Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volumn (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
|---|---|---|---|---|---|---|---|
| LPCN | $4.89 | -6.501% | 31 | 29 | $26 | $2.86 | 71.0% |
Lipocine Inc.
675 Arapeen Drive
Suite 202
Salt Lake City, UT 84108
United States
Lipocine Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. The company develops drugs based on Hydroance, a drug delivery technology. It primarily focuses on developing oral versions of several hormones for use in men and women health. The company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. It also offers custom drugs for pharmaceutical/biotechnology companies. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.